INS and fatty liver disease: Increased fructose intake has been shown to increase triglycerides (63), stimulate de novo lipogenesis, oxidative stress (61), and inflammation (63), and decrease hepatic insulin sensitivity (62), all of which may contribute to the development and progression of hepatic steatosis and MetS (63).